Target intelligence / Profile preview

Immunoglobulin heavy diversity 3-16 (IGHD3-16)

Target
IGHD3-16
Molecular classification
Immunoglobulin gene segment, Immunoglobulin diversity gene
01

Overview

Immunoglobulin heavy diversity 3-16 (IGHD3-16) is one of several human immunoglobulin heavy chain diversity (D) gene segments that contribute to the enormous variability of antibodies produced by B lymphocytes. These D gene segments are not translated into proteins by themselves, but are instead recombined with variable (V) and joining (J) gene segments during early B cell development through V(D)J recombination. This process generates highly diverse immunoglobulin heavy chain variable regions, which, when paired with light chains, produce the antigen-binding diversity fundamental to adaptive immunity. IGHD3-16 itself is not a therapeutic target and is not associated with any drugs, diseases, or safety concerns. Its only direct function is contributing sequence diversity to the third complementarity-determining region (CDR3) of immunoglobulin heavy chains.

Other names
IGHD316IGHD3-16
02

Biological functions

Generation of antibody (immunoglobulin) diversityComponent of somatic V(D)J recombination in B cells

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 3-16 (IGHD3-16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 3-16 (IGHD3-16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call